Latest News about OCUL
Recent news which mentions OCUL
3 Top Healthcare Stocks to Buy Now
February 17, 2021
From Motley Fool
3 Reasons to Buy Ocular Therapeutix Stock Right Now
February 16, 2021
From Motley Fool
Ocular Therapeutix's Intravitreal Implant Shows Decrease In Retinal Fluid In Early-Stage Wet AMD Study
February 16, 2021
Tickers
OCUL
From Benzinga
10 Health Care Stocks With Unusual Options Alerts In Today's Session
January 04, 2021
From Benzinga
Benzinga's Top Upgrades, Downgrades For December 17, 2020
December 17, 2020
From Benzinga
The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut
December 17, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
December 16, 2020
From Benzinga
The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal
December 16, 2020
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Monday
December 14, 2020
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street
December 11, 2020
From Benzinga
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
December 08, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
December 07, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
December 04, 2020
From Benzinga
The Daily Biotech Pulse: BioCryst's Heredity Angioedema Treatment Clears FDA, Sutro Biopharma Readout, 2 IPOs
December 04, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
December 03, 2020
From Benzinga
The Daily Biotech Pulse: Lilly Secures Additional Orders For COVID-19 Antibody Treatment, Decision Day For BioCryst, Kinnate Biopharma To Make Wall Street Debut
December 03, 2020
From Benzinga
The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit
December 01, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
November 30, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
November 27, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
November 25, 2020
From Benzinga
The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback
November 25, 2020
From Benzinga
The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia
November 24, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
November 23, 2020
From Benzinga
The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration
November 17, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
November 16, 2020
From Benzinga
The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations
November 13, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
November 12, 2020
From Benzinga
The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap
November 11, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.